InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2026-03-16 | Kevin Hern(R-OK01) | house | Sale | $50,001 - $100,000 |
| 2025-05-15 | Rob Bresnahan(R-PA08) | house | Sale | $1,001 - $15,000 |
| 2025-04-08 | Rob Bresnahan(R-PA08) | house | Purchase | $15,001 - $50,000 |
| 2025-02-25 | Rob Bresnahan(R-PA08) | house | Sale | $1,001 - $15,000 |
No financial data available for IQV.
Company may not file with SEC or CIK is unresolved.
Lilly CEO says Foundayo launch will be "just fine"
A Look At IQVIA Holdings (IQV) Valuation After ESOP Linked Shelf Registration For Potential Share Issuance
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
Can Eli Lilly’s Foundayo Catch Up to Novo’s Wegovy Pill?
Eli Lilly slips as obesity scripts said to trail those for Novo’s Wegovy
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
Lilly weight loss pill prescriptions said to near 1,400 in first week of launch
OpenAI launches GPT-Rosalind, an AI model for life sciences research
IQVIA.ai Launch With NVIDIA Puts IQVIA’s AI Valuation In Focus
IQVIA to Announce First-Quarter 2026 Results on May 5, 2026
Lilly Stock Dips on FDA Request for More Foundayo Safety Data. Is the Market Reaction Overblown?